Related references
Note: Only part of the references are listed.Resveratrol in cancer management: where are we and where we go from here?
Mary Ndiaye et al.
RESVERATROL AND HEALTH (2011)
Effect of food on the pharmacokinetic profile of trans-resveratrol
M. Vaz-da-Silva et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Disruption of Androgen and Estrogen Receptor Activity in Prostate Cancer by a Novel Dietary Diterpene Carnosol: Implications for Chemoprevention
Jeremy J. Johnson et al.
CANCER PREVENTION RESEARCH (2010)
Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
H-H. Sherry Chow et al.
CANCER PREVENTION RESEARCH (2010)
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Victoria A. Brown et al.
CANCER RESEARCH (2010)
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Yong Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Green tea polyphenols for prostate cancer chemoprevention: A translational perspective
J. J. Johnson et al.
PHYTOMEDICINE (2010)
Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
Luis Almeida et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides -: Two novel resveratrol metabolites in human plasma
Alexander Burkon et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Resveratrol imparts photoprotection of normal cells and enhances the efficacy of radiation therapy in cancer cells
Shannon Reagan-Shaw et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2008)
Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent
David J. Boocock et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential
Sharmila Shankar et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Oncogenicity evaluation of resveratrol in p53((+/-)) (p53 knockout) mice
T. L. Horn et al.
FOOD AND CHEMICAL TOXICOLOGY (2007)
Black pepper and its pungent principle-piperine: A review of diverse physiological effects
K. Srinivasan
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2007)
Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms
SS Brill et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene
S Sale et al.
BRITISH JOURNAL OF CANCER (2004)
High absorption but very low bioavailability of oral resveratrol in humans
T Walle et al.
DRUG METABOLISM AND DISPOSITION (2004)
Characterization of a new rat urinary metabolite of piperine by LC/NMR/MS studies
S Bajad et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model
JF Marier et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Piperine inhibits gastric emptying and gastrointestinal transit in rats and mice
S Bajad et al.
PLANTA MEDICA (2001)